Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$42.05 - $47.77 $2.75 Million - $3.12 Million
-65,300 Reduced 64.91%
35,300 $1.54 Million
Q1 2022

May 12, 2022

SELL
$40.23 - $47.74 $2.59 Million - $3.08 Million
-64,500 Reduced 39.07%
100,600 $4.38 Million
Q4 2021

Jan 28, 2022

SELL
$38.88 - $45.31 $466,560 - $543,720
-12,000 Reduced 6.78%
165,100 $7.28 Million
Q1 2021

Apr 30, 2021

SELL
$34.27 - $40.01 $15.4 Million - $18 Million
-450,000 Reduced 71.76%
177,100 $6.32 Million
Q4 2020

Feb 08, 2021

SELL
$34.07 - $39.94 $4.2 Million - $4.92 Million
-123,200 Reduced 16.42%
627,100 $23.1 Million
Q2 2020

Aug 05, 2020

BUY
$37.87 - $43.58 $7.06 Million - $8.12 Million
186,300 Added 33.03%
750,300 $30.6 Million
Q1 2020

May 07, 2020

BUY
$32.47 - $48.83 $288,983 - $434,587
8,900 Added 1.6%
564,000 $21.4 Million
Q4 2019

Feb 10, 2020

BUY
$42.0 - $48.25 $33,600 - $38,600
800 Added 0.14%
555,100 $26.1 Million
Q3 2019

Nov 07, 2019

BUY
$40.46 - $43.52 $60,690 - $65,280
1,500 Added 0.27%
554,300 $23.7 Million
Q2 2019

Aug 08, 2019

BUY
$39.4 - $42.7 $5.32 Million - $5.76 Million
135,000 Added 32.31%
552,800 $22.1 Million
Q1 2019

May 07, 2019

SELL
$38.57 - $42.69 $287,346 - $318,040
-7,450 Reduced 1.75%
417,800 $17.5 Million
Q4 2018

Feb 05, 2019

SELL
$37.8 - $42.69 $2.09 Million - $2.37 Million
-55,400 Reduced 11.53%
425,250 $16.2 Million
Q3 2018

Nov 06, 2018

BUY
$39.75 - $42.69 $610,162 - $655,291
15,350 Added 3.3%
480,650 $19.3 Million
Q2 2018

Aug 08, 2018

SELL
$39.61 - $42.76 $166,362 - $179,592
-4,200 Reduced 0.89%
465,300 $18.8 Million
Q1 2018

May 04, 2018

SELL
$36.18 - $40.15 $50,652 - $56,210
-1,400 Reduced 0.3%
469,500 $18.3 Million
Q4 2017

Feb 01, 2018

BUY
$35.34 - $41.9 $3.87 Million - $4.59 Million
109,500 Added 30.3%
470,900 $0
Q3 2017

Nov 13, 2017

BUY
$39.44 - $41.55 $14.3 Million - $15 Million
361,400
361,400 $14.7 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.